BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22928861)

  • 1. The effects of abrupt antipsychotic discontinuation in cognitively impaired older persons: a pilot study.
    Azermai M; Petrovic M; Engelborghs S; Elseviers MM; Van der Mussele S; Debruyne H; Van Bortel L; Vander Stichele RH
    Aging Ment Health; 2013; 17(1):125-32. PubMed ID: 22928861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antipsychotic withdrawal on behavior and sleep/wake activity in nursing home residents with dementia: a randomized, placebo-controlled, double-blinded study. The Bergen District Nursing Home Study.
    Ruths S; Straand J; Nygaard HA; Bjorvatn B; Pallesen S
    J Am Geriatr Soc; 2004 Oct; 52(10):1737-43. PubMed ID: 15450054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of controlled discontinuation of long-term used antipsychotics for behavioural symptoms in individuals with intellectual disability.
    de Kuijper G; Evenhuis H; Minderaa RB; Hoekstra PJ
    J Intellect Disabil Res; 2014 Jan; 58(1):71-83. PubMed ID: 23046144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole for the treatment of psychoses in institutionalized patients with Alzheimer dementia: a multicenter, randomized, double-blind, placebo-controlled assessment of three fixed doses.
    Mintzer JE; Tune LE; Breder CD; Swanink R; Marcus RN; McQuade RD; Forbes A
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):918-31. PubMed ID: 17974864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stopping antipsychotic drug therapy in demented nursing home patients: a randomized, placebo-controlled study--the Bergen District Nursing Home Study (BEDNURS).
    Ruths S; Straand J; Nygaard HA; Aarsland D
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):889-95. PubMed ID: 18306150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yokukansan treatment of chronic renal failure patients receiving hemodialysis, with behavioral and psychological symptoms of dementia: an open-label study.
    Sumiyoshi H; Mantani A; Nishiyama S; Fujiwaki S; Ohta S; Masuda Y; Tomita Y; Tarumoto N; Yamawaki S
    Am J Geriatr Psychiatry; 2013 Nov; 21(11):1082-5. PubMed ID: 23567442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: is the long lasting use of atypical antipsychotic drugs useful and safe?
    Angelini A; Bendini C; Neviani F; Neri M
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():35-43. PubMed ID: 17317431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antipsychotics against anxiety in dementia: medical treatment or chemical restraints?].
    Ruths S; Straand J
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1672-5. PubMed ID: 15976839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.
    Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exploratory open-label trial of ziprasidone for the treatment of behavioral and psychological symptoms of dementia.
    Rocha FL; Hara C; Ramos MG; Kascher GG; Santos MA; de Oliveira Lança G; Magalhães Scoralick F
    Dement Geriatr Cogn Disord; 2006; 22(5-6):445-8. PubMed ID: 16983187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.
    Monji A; Takita M; Samejima T; Takaishi T; Hashimoto K; Matsunaga H; Oda M; Sumida Y; Mizoguchi Y; Kato T; Horikawa H; Kanba S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):308-11. PubMed ID: 19138715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of antipsychotics and neuropsychiatric symptoms on the quality of life of people with dementia living in nursing homes.
    van de Ven-Vakhteeva J; Bor H; Wetzels RB; Koopmans RT; Zuidema SU
    Int J Geriatr Psychiatry; 2013 May; 28(5):530-8. PubMed ID: 22886912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: The Role of Hallucinations.
    Patel AN; Lee S; Andrews HF; Pelton GH; Schultz SK; Sultzer DL; Mintzer J; de la Pena D; Gupta S; Colon S; Schimming C; Levin B; Devanand DP
    Am J Psychiatry; 2017 Apr; 174(4):362-369. PubMed ID: 27855483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zotepine for behavioural and psychological symptoms in dementia: an open-label study.
    Rainer MK; Mucke HA; Krüger-Rainer C; Haushofer M; Kasper S
    CNS Drugs; 2004; 18(1):49-55. PubMed ID: 14731059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin.
    Hamuro A; Saito S
    Psychogeriatrics; 2010 Dec; 10(4):198-200. PubMed ID: 21159055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of neuropsychiatric symptoms and daily functioning of patients with dementia treated on an acute psychogeriatric ward.
    Pitkänen A; Alanen HM; Kampman O; Leinonen E
    Nord J Psychiatry; 2018 Oct; 72(7):521-525. PubMed ID: 30445895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The persistence of neuropsychiatric symptoms in dementia: the Cache County Study.
    Steinberg M; Tschanz JT; Corcoran C; Steffens DC; Norton MC; Lyketsos CG; Breitner JC
    Int J Geriatr Psychiatry; 2004 Jan; 19(1):19-26. PubMed ID: 14716695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.